Last reviewed · How we verify
NCT03543917: PSIOM
Post-Stroke Improvement of Motor Function
Phase 1 trial testing Perfusion with New Combination Medication in Cerebrovascular Accident in 17 participants. Completed in 29 September 2018.
30 August 2018
Quick facts
| Lead sponsor | Fundatia Bio-Forum |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 17 |
| Start date | 8 August 2017 |
| Primary completion | 30 August 2018 |
| Estimated completion | 29 September 2018 |
| Sites | 1 location across Romania |
Drugs / interventions tested
- Perfusion with New Combination Medication
Conditions studied
- Cerebrovascular Accident — all drugs for Cerebrovascular Accident →
Sponsor
Fundatia Bio-Forum
Who can join
Adults 18 to 80, any sex, with Cerebrovascular Accident. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open-label clinical study where all new patients presenting with cerebrovascular accidents and consenting to treatment are given intravenously a new combination of medications. Patients are evaluated neurologically with NIHSS scores before treatment administration and at 1 month after the first treatment. Further evaluations at 6 months after treatment by NIHSS and Barthel scores are ongoing
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Targeting Neutrophil Extracellular Traps: A New Strategy for the Treatment of Acute Ischemic Stroke Based on Thrombolysis Resistance.
Huang G, Wu H, Lin B, Deng D, et al · · 2026 · cited 3× · PMID 40461018 · DOI 10.1055/a-2609-3457
Verify or expand the search:
- PubMed search for NCT03543917
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebrovascular Accident
Currently open trials in the same condition.
- NCT07272239 — Effects of tVNS and mCIMT in Chronic Stroke · NA · recruiting
- NCT06498011 — COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO) · NA · recruiting
- NCT06521801 — Cardio-Renal Registry · recruiting
- NCT06371937 — iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease · recruiting
- NCT06107010 — Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Sub · NA · recruiting
Other Fundatia Bio-Forum trials
Trials by the same sponsor.
- NCT04007224 — Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder · Phase 1 · completed
- NCT03535974 — Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03543917 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundatia Bio-Forum
- Last refreshed: 19 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543917.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing